Inhibitory Effect of Honey on 7,12-Dimethylbenz(a)anthracene- Initiated and Croton Oil-Promoted Skin Carcinogenesis


Sauda Meskini Milani 1 , 2 , Moslem Najafi 1 , Parisa Alizadeh 1 , Hassan Rezazadeh 1 , *

1 Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran

2 Department of Toxicology, Ahar Branch, Islamic Azad University, Ahar, Iran

How to Cite: Meskini Milani S, Najafi M, Alizadeh P, Rezazadeh H. Inhibitory Effect of Honey on 7,12-Dimethylbenz(a)anthracene- Initiated and Croton Oil-Promoted Skin Carcinogenesis, Jundishapur J Nat Pharm Prod. 2018 ; 13(3):e57992. doi: 10.5812/jjnpp.57992.


Jundishapur Journal of Natural Pharmaceutical Products: 13 (3); e57992
Published Online: August 27, 2018
Article Type: Research Article
Received: October 3, 2016
Revised: December 6, 2017
Accepted: February 18, 2018


Background: Honey as a natural product exhibits a variety of biological and pharmacological activities. Its anti-inflammatory, antioxidant, antibacterial, and antihypertensive effects have already been proven.

Objectives: In this study, the inhibitory effects of honey on the 7,12-dimethylbenz(a)anthracene-initiated and croton oil-promoted mice skin carcinogenesis were studied.

Methods: Albino Swiss mice were pretreated with multiple topical applications of honey. After nine hours, the carcinogenesis was initiated by a single dose of DMBA. Topical croton oil, as for a promoting agent, was applied biweekly for a period of 30 weeks.

Results: The tumor incidences were observed. Compared to the control group, the honey pre-treated mice showed a significant inhibition in tumor incidences. In addition, the enhanced uptake of [3H]-thymidine in mice skin DNA was inhibited in honey-pretreated animals as compared to the control group.

Conclusions: Taken together, the results suggest that the antioxidants existed in honey have diminishing effects on croton oil-mediated murine skin tumor promotion. In conclusion, we suggest that honey as an effective natural preventive agent may provide protection against skin cancer.

1. Background

There has been a lot of effort to identify natural products that may decrease the effects of carcinogenic substances in the environment. Honey is being used in traditional medicine for centuries. Humans evidently began to use honey dating back to 8000 years as shown by cave pictures (1). It has been therapeutically used by ancient Asian and European nations against wounds and gastrointestinal diseases (2). Furthermore, during the past few decades, honey played an important role in the indigenous medicine and has been used in laboratory and clinical studies. The most notable reports were on its antibacterial activities (3-6). Moreover, honey is widely recognized for its skin injuries healing. It provides a decreased dehydration environment that promotes wound healing. However, it is in a sticky fluid shape and topically is used to protect against infections.

The antibacterial and tissue repair activities of honey are related to its low acidity and release of the least amount of hydrogen peroxide (7, 8). The recent clinical case studies indicate that honey actively involves in the treatment of cutaneous infections (9).

The exact components of honey depend on bee feeding from different botanical sources.

In addition, honey samples contain different compositions of flavonoids and phenolic acids that synergistically act as antioxidants (6, 10-13).

Honey has been reported to have immunomodulatory activities (14) and is able to repair wound tissues by modulating the activity of monocyte cells and releasing anti-inflammatory cytokines (15). The role of honey in the treatment of rats bowel inflammation was investigated (16). The anti-inflammatory effects are due to a depletion in plasma concentrations of thromboxane B2, prostaglandin E2 (PGE2), and PGF, as well as the synergic effect of the phenolic compounds identified in the honey (17, 18).

The in vitro studies indicate that honey participates in cardiovascular protection by inhibiting the low-density lipoprotein oxidation and scavenging the generated reactive oxygen species (19-22).

Today, the cancer incidence is one of the human problems on which, excessive research has been performed to prevent the tumor growth. Scientists have considered skin cancer and attempted to treat skin tumors by using natural compounds (23).

So far, most of the studies investigated the potential benefits of honey in the general human health, but its efficacy on skin tumor treatment is not completely clear. It is reported that skin application of honey had an essential role in the treatment of radiation mucositis (24). In addition, honey has an antineoplastic activity in human bladder cancer cell lines and considerably is effective against implanted tumor growth in mice (25, 26).

According to these studies, it seems that honey acts through different mechanisms to inhibit the tumorigenesis potential. Recently, we have shown that during pregnancy, the body iron level plays an essential role in skin tumor incidence (27). Moreover, in another study, we showed the inhibitory effects of tannic acid on 7,12-dimethylbenz(a)anthracene (DMBA)-initiated mice skin carcinogenesis (28).

Thereby, the antioxidant property of honey may chelate the generated oxidant and decrease skin tumors. Hence, this study focused on the effect of honey on DMBA and croton oil-induced mice skin tumorigenesis.

2. Methods

2.1. Chemicals

The hair-removing cream was purchased from Tolidaro, Iran. Croton oil and DMBA were procured from Sigma (St. Louis, MO) Chemical Co., USA. [3H]-thymidine (specific activity of 82 Ci/mmol) was obtained from Amersham Corporation, UK. All other chemicals and biochemicals used in this study were either of analytical grade or of the highest purity grade available commercially.

2.2. Honey Sample

Floral honey was obtained from an authorized apiary at Oskou Agriculture Department situated in East Azerbaijan, Iran. Honey was sterilized by gamma-irradiation (25 kGy) and kept at room temperature away from direct sunlight.

2.3. Animals

In this study, Swiss albino female mice were obtained from the Central Animal House of Tabriz University of Medical Sciences. The animals were kept in polypropylene cages. For chronic (tumorigenesis) experiments, 20 mice and for acute experiments, six mice were housed in each group. They had a free access to a pellet diet and water ad libitum. The animals were kept at room temperature and exposed to 12-hour light and darkness cycles. The dorsal skin of the mice was shaved 48 hours before the treatment. Only those mice that did not show hair re-growth were used. The experiments were carried out in accordance with the Guide for the Care and Use of Laboratory Animals (Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council, National Academy Press, Washington, D.C. 1996).

2.4. Treatment of Animals and Tumorigenesis Studies

A total of 80 female Swiss mice were divided into four groups, 20 mice per group. Group I served as a positive control. Groups II, III, and IV were pretreated topically with honey dose-dependently at 100, 200, and 300 mg/mouse for two weeks. Six hours after the treatment with honey, the animals of all the four groups received a single topical application of DMBA (40 μg/100 μL acetone/mouse). One week after the application of DMBA, these animals were given a twice a week application of croton oil (0.5 mg/200 μL acetone/mouse) for a period of 30 weeks. The criteria for the diagnoses of tumors were the same as described by O'Connell et al. (29).

The mice were monitored for the incidence of tumors, which were recorded and plotted as a function of weeks on the test. The number of tumors per mouse and percentage of tumorigenesis incidence were recorded.

For studying the effect of honey on [3H]-thymidine incorporation into cutaneous DNA, according to the experimental protocol, 24 mice were divided into four groups (6 in each group) while group I served as the saline control. Groups II and IV were pretreated topically with honey (300 mg/mouse) for two weeks. After 3 hours, the animals of groups III and IV were treated with a single topical application of croton oil. After 18 hours, all the animals of the four groups were given an i.p. injection of [3H]-thymidine (15.0 μCi per animal per 0.2 mL saline). After 2 hours, all animals were sacrificed by cervical dislocation. Their skin tissues were removed, cleaned free of extraneous material, and processed for DNA separation.

2.5. [3H]-Thymidine Incorporation Assay

The incorporation of [3H]-thymidine in the epidermal DNA was done according to the method described by Smart et al. (30). Briefly, for obtaining clean epidermis, the skin was cleaned and a 10% homogenate (w/v) of skin tissue was prepared in ice-cold water containing an equal volume of ice-cold TCA (10%). The precipitate was washed with 5% of cold TCA and incubated with 10% of cold perchloric acid at 4ºC for 8 hours. After centrifugation, the precipitate was washed with 5% cold perchloric acid. The precipitate was dissolved in warm 10% perchloric acid followed by incubation in a boiling water bath for 30 minutes and then filtered through a Whatman 50 paper filter. The filtrate was counted for [3H]-thymidine. For counting in the sample, a fixed volume of this solution was added to the scintillation counter (LKB-Wallace-1410). The amount of DNA in the filtrate was estimated by the diphenylamine method of Giles and Myers and expressed as [3H] DPM/mg DNA (31).

2.6. Statistical Analysis

The Dunnett's t-test was used to obtain the level of significance between different groups followed by the analysis of variance test. The level of significance was set at P < 0.05.

3. Results

The effects of topical pretreatment with honey on the number of tumor and tumor incidences are shown in Figures 1 and 2, respectively. Figure 1 shows that the tumors significantly reduced in honey-pretreated animals as compared to the untreated positive control group.

Figure 1. Effect of honey on the yield of cutaneous tumors developed because of DMBA initiation and croton oil promotion in mice. The tumors were counted every week and are represented as the number of tumors per mouse plotted as a function of weeks on the test. Each value represents the mean number of tumors per mouse.
Figure 2. Effect of honey on percentage incidence of cutaneous tumors in DMBA-initiated and croton oil-promoted mice. The data were recorded every week and plotted as a function of weeks on the test. Each value represents the mean incidence based on the data of 20 animals.

As shown in Figure 1, by week 22, the tumor yield in the DMBA-initiated and croton oil-promoted animals was 2/mouse while at the same time, in honey treated animals, there was more than an eight-fold reduction in the tumor number and the observed data were lest then 0.30 tumors/mouse. However, there were no tumor incidences in the corresponding groups of animals receiving only honey, acetone, DMBA, and croton oil alone.

Therefore, the tumor incidence was zero in the animals that received only acetone, DMBA, croton oil, and honey alone. That is, these animals did not develop any tumors during the course of the experiment.

In a similar way, the effect of honey on the percentage of mice skin tumor is shown in Figure 2. By week 23, in DMBA and croton oil-treated animals, the tumor incidence was up to 50%; however, at this moment, the incidence was about 5% among honey-pretreated animals.

The effect of honey on [3H]-thymidine incorporation into cutaneous DNA is shown in Figure 3. As compared to the saline control group, about a three-fold increase in [3H]-thymidine incorporation in croton oil-treated animals was observed, while the application of honey significantly decreased this effect.

Figure 3. Effect of Honey on the inhibition of [3H]-thymidine incorporation into cutaneous DNA in mice. Exact treatment protocol and other experimental details are given in the text. Each value represents the mean ± SD of six animals (P < 0.05 when compared to saline-treated control mice).

4. Discussion

The present study provides the first evidence that a topical application of honey inhibits the carcinogenic effects of DMBA and croton oil on mice skin.

Chemoprevention, which uses pharmacological agents with appropriate pharmacological properties (32, 33) or dietary materials, has been utilized in different forms such as macronutrients, micronutrients, and various phytochemicals (34-36). Recently, dietary manipulations, which affect the development of cancer, have been highlighted. Natural honey is rich in potent antioxidants, especially various polyphenols (37).

Studies have also been conducted to examine the effect of diet on the cause and augmentation of cancer. Results of some epidemiological investigations have also remarked that diet is an important risk factor for many common cancers (38). To date, a lot of natural antimutagenic chemical compounds with different chemical structures have been identified in human diet (39).

However, the inhibitory mechanisms in these studies appear to be due to the suppression of polycyclic aromatic hydrocarbons (PAHs) xenobiotic-metabolizing enzymes and finally, forming a stable bound with DNA (40).

In the present study, the detected reduction in the tumor incidence and tumor yield in honey-pretreated animals before DMBA suggested that honey might also function as a potent inhibitor of DMBA metabolites at the initiation stage so that the removal of generated peroxy radical, which participated in the production of DMBA metabolite, may play an essential role in the reduction of skin tumorigenesis.

Moreover, the decreased level of [3H]-thymidine incorporation into cutaneous DNA among honey pretreated mice suggests that binding some chemical compounds of natural honey to DNA plays an essential role in the DMBA and croton oil-induced skin tumorigenesis.

In conclusion, we suggest that honey as an effective natural preventive agent may provide protection against skin cancer.



  • 1.

    Bansal V, Medhi B, Pandhi P. Honey--a remedy rediscovered and its therapeutic utility. Kathmandu Univ Med J (KUMJ). 2005;3(3):305-9. [PubMed: 18650599].

  • 2.

    Al-Jabri AA. Honey, milk and antibiotics. Afr J Biotechnol. 2005;4(13).

  • 3.

    Al-Waili NS, Haq A. Effect of honey on antibody production against thymus-dependent and thymus-independent antigens in primary and secondary immune responses. J Med Food. 2004;7(4):491-4. doi: 10.1089/jmf.2004.7.491. [PubMed: 15671696].

  • 4.

    Emsen IM. A different and safe method of split thickness skin graft fixation: medical honey application. Burns. 2007;33(6):782-7. doi: 10.1016/j.burns.2006.12.005. [PubMed: 17601670].

  • 5.

    Jeffrey AE, Echazarreta CM. Medical uses of honey. Rev Biomed. 1996;7(1):43-9.

  • 6.

    Alvarez-Suarez JM, Tulipani S, Romandini S, Bertoli E, Battino M. Contribution of honey in nutrition and human health: a review. Med J Nutrition Metab. 2010;3(1):15-23.

  • 7.

    Lusby PE, Coombes AL, Wilkinson JM. Bactericidal activity of different honeys against pathogenic bacteria. Arch Med Res. 2005;36(5):464-7. doi: 10.1016/j.arcmed.2005.03.038. [PubMed: 16099322].

  • 8.

    Cooper R. Honey for wound care in the 21st century. J Wound Care. 2016;25(9):544-52. doi: 10.12968/jowc.2016.25.9.544. [PubMed: 27608516].

  • 9.

    Visavadia BG, Honeysett J, Danford MH. Manuka honey dressing: An effective treatment for chronic wound infections. Br J Oral Maxillofac Surg. 2008;46(1):55-6. doi: 10.1016/j.bjoms.2006.09.013. [PubMed: 17113690].

  • 10.

    Johnston JE, Sepe HA, Miano CL, Brannan RG, Alderton AL. Honey inhibits lipid oxidation in ready-to-eat ground beef patties. Meat Sci. 2005;70(4):627-31. doi: 10.1016/j.meatsci.2005.02.011. [PubMed: 22063889].

  • 11.

    Turkmen N, Sari F, Poyrazoglu ES, Velioglu YS. Effects of prolonged heating on antioxidant activity and colour of honey. Food Chem. 2006;95(4):653-7.

  • 12.

    Rakha MK, Nabil ZI, Hussein AA. Cardioactive and vasoactive effects of natural wild honey against cardiac malperformance induced by hyperadrenergic activity. J Med Food. 2008;11(1):91-8. doi: 10.1089/jmf.2006.172. [PubMed: 18361743].

  • 13.

    Al-Mamary M, Al-Meeri A, Al-Habori M. Antioxidant activities and total phenolics of different types of honey. Nutr Res. 2002;22(9):1041-7.

  • 14.

    Henriques A, Jackson S, Cooper R, Burton N. Free radical production and quenching in honeys with wound healing potential. J Antimicrob Chemother. 2006;58(4):773-7. doi: 10.1093/jac/dkl336. [PubMed: 16963460].

  • 15.

    Tonks AJ, Cooper RA, Jones KP, Blair S, Parton J, Tonks A. Honey stimulates inflammatory cytokine production from monocytes. Cytokine. 2003;21(5):242-7. [PubMed: 12824009].

  • 16.

    Bilsel Y, Bugra D, Yamaner S, Bulut T, Cevikbas U, Turkoglu U. Could honey have a place in colitis therapy? Effects of honey, prednisolone, and disulfiram on inflammation, nitric oxide, and free radical formation. Dig Surg. 2002;19(4):306-11. discussion 311-2. doi: 10.1159/000064580. [PubMed: 12207075].

  • 17.

    Al-Waili NS, Boni NS. Natural honey lowers plasma prostaglandin concentrations in normal individuals. J Med Food. 2003;6(2):129-33. doi: 10.1089/109662003322233530. [PubMed: 12935324].

  • 18.

    Borsato DM, Prudente AS, Doll-Boscardin PM, Borsato AV, Luz CF, Maia BH, et al. Topical anti-inflammatory activity of a monofloral honey of Mimosa scabrella provided by Melipona marginata during winter in southern Brazil. J Med Food. 2014;17(7):817-25. doi: 10.1089/jmf.2013.0024. [PubMed: 24650139].

  • 19.

    Ahmad A, Khan RA, Mesaik MA. Anti inflammatory effect of natural honey on bovine thrombin-induced oxidative burst in phagocytes. Phytother Res. 2009;23(6):801-8. doi: 10.1002/ptr.2648. [PubMed: 19142984].

  • 20.

    Hegazi AG, Abd El-Hady FK. Influence of honey on the suppression of human low density lipoprotein (ldl) peroxidation (in vitro). Evid Based Complement Alternat Med. 2009;6(1):113-21. doi: 10.1093/ecam/nem071. [PubMed: 18955249]. [PubMed Central: PMC2644272].

  • 21.

    Najafi M, Mahdizadeh Aghdam E, Rafiei F, Eteraf Oskouei T. Effects of pharmacologic preconditioning by natural honey on arrhythmias and infarct size in isolated heart. Pharm Sci. 2008;(4):1-11.

  • 22.

    Najafi M, Shaseb E, Ghaffary S, Fakhrju A, Eteraf Oskouei T. Effects of chronic oral administration of natural honey on ischemia/reperfusion-induced arrhythmias in isolated rat heart. Iran J Basic Med Sci. 2011;14(1):75-81.

  • 23.

    Costa A, Bonner MY, Arbiser JL. Use of polyphenolic compounds in dermatologic oncology. Am J Clin Dermatol. 2016;17(4):369-85. doi: 10.1007/s40257-016-0193-5. [PubMed: 27164914]. [PubMed Central: PMC5901676].

  • 24.

    Biswal BM, Zakaria A, Ahmad NM. Topical application of honey in the management of radiation mucositis: a preliminary study. Support Care Cancer. 2003;11(4):242-8. doi: 10.1007/s00520-003-0443-y. [PubMed: 12673463].

  • 25.

    Swellam T, Miyanaga N, Onozawa M, Hattori K, Kawai K, Shimazui T, et al. Antineoplastic activity of honey in an experimental bladder cancer implantation model: in vivo and in vitro studies. Int J Urol. 2003;10(4):213-9. [PubMed: 12657101].

  • 26.

    Hamzaoglu I, Saribeyoglu K, Durak H, Karahasanoglu T, Bayrak I, Altug T, et al. Protective covering of surgical wounds with honey impedes tumor implantation. Arch Surg. 2000;135(12):1414-7. [PubMed: 11115344].

  • 27.

    Rezazadeh H, Nayebi AR, Athar M. Role of iron-dextran on 7,12-dimethylbenz(a) anthracene-initiated and croton oil-promoted cutaneous tumorigenesis in normal and pregnant mice. Hum Exp Toxicol. 2001;20(9):471-6. doi: 10.1191/096032701682693044. [PubMed: 11776409].

  • 28.

    Babaei H, Mohajjel Nayebi AR, Rezazadeh H, Abdulla M. Inhibitory effect of tannic acid on iron–dextran‐augmented and 7, 12‐dimethyl benz (a) anthracene‐initiated skin carcinogenesis. J Trace Elem Exp Med. 2004;17(1):21-9. doi: 10.1002/jtra.10049.

  • 29.

    O'Connell JF, Klein-Szanto AJ, DiGiovanni DM, Fries JW, Slaga TJ. Enhanced malignant progression of mouse skin tumors by the free-radical generator benzoyl peroxide. Cancer Res. 1986;46(6):2863-5. [PubMed: 3084079].

  • 30.

    Smart RC, Huang MT, Conney AH. sn-1,2-Diacylglycerols mimic the effects of 12-O-tetradecanoylphorbol-13-acetate in vivo by inducing biochemical changes associated with tumor promotion in mouse epidermis. Carcinogenesis. 1986;7(11):1865-70. [PubMed: 3769135].

  • 31.

    Giles KW, Myers A. An improved diphenylamine method for the estimation of deoxyribonucleic acid. Nature. 1965;206(93). doi: 10.1038/206093a0.

  • 32.

    Stoner GD, Morse MA, Kelloff GJ. Perspectives in cancer chemoprevention. Environ Health Perspect. 1997;105 Suppl 4:945-54. [PubMed: 9255586]. [PubMed Central: PMC1470021].

  • 33.

    Kelloff GJ, Hawk ET, Sigman CC, editors. Cancer chemoprevention: Promising cancer chemopreventive agents. 1. Totowa, NJ, USA: Humana Press; 2004.

  • 34.

    Zubair H, Azim S, Ahmad A, Khan MA, Patel GK, Singh S, et al. Cancer chemoprevention by phytochemicals: Nature's healing touch. Molecules. 2017;22(3). doi: 10.3390/molecules22030395. [PubMed: 28273819].

  • 35.

    Ferguson LR, Philpott M, Karunasinghe N. Dietary cancer and prevention using antimutagens. Toxicology. 2004;198(1-3):147-59. doi: 10.1016/j.tox.2004.01.035. [PubMed: 15138038].

  • 36.

    Surh YJ. Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer. 2003;3(10):768-80. doi: 10.1038/nrc1189. [PubMed: 14570043].

  • 37.

    Kesic A, Crnkic A, Ibrisimovic-Mehmedinovic N, Sestan A, Catovic B. Changes of antioxidant activity in honey as a result of Haber-Wais reaction. Am J App Chem. 2014;2(6):112-6. doi: 10.11648/j.ajac.20140206.13.

  • 38.

    Willett WC. Diet and cancer. Oncologist. 2000;5(5):393-404. [PubMed: 11040276].

  • 39.

    Olsen SJ, Love RR. A new direction in preventive oncology: Chemoprevention. Semin Oncol Nurs. 1986;2(3):211-21. doi: 10.1016/s0749-2081(86)80011-0.

  • 40.

    Slaga TJ, Solanki V, Logani M. Studies on the mechanism of action of antitumor promoting agents: Suggestive evidence for the involvement of free radicals in promotion. In: Nygaard OF, Simic MG, editors. Radioprotectors and anticarcinogens. New York: Academic Press; 1983. p. 471-85.

  • Copyright © 2018, Jundishapur Journal of Natural Pharmaceutical Products. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.